Question 1

What is autosomal dominant aplasia and myelodysplasia?

Accepted Answer

Autosomal dominant aplasia and myelodysplasia is a condition primarily affecting the bone marrow, leading to abnormal blood cell development and bone marrow failure. It is associated with changes in the SRP72 gene, which plays a role in protein targeting within cells. Individuals with this condition may present with features such as reduced bone marrow cellularity and blood count abnormalities, along with sensorineural hearing impairment. The condition is very rare, affecting fewer than 1 in 1,000,000 people.

Question 2

What are the symptoms of autosomal dominant aplasia and myelodysplasia?

Accepted Answer

The clinical presentation of autosomal dominant aplasia and myelodysplasia is variable and primarily involves the hematologic system. Many affected individuals experience bone marrow hypocellularity, myelodysplasia, and in some cases, pancytopenia or aplastic anemia, which can lead to fatigue and increased susceptibility to infections. Additionally, sensorineural hearing impairment is noted in a considerable subset of patients. Not all individuals experience all these features, and severity varies considerably.

Question 3

What causes autosomal dominant aplasia and myelodysplasia?

Accepted Answer

This condition is caused by pathogenic variants in the SRP72 gene. The SRP72 gene encodes a component of the signal recognition particle complex, which is essential for directing proteins to their proper destinations in the cell. The autosomal dominant inheritance pattern means that having a single altered copy of this gene can be sufficient to cause the disease, and there is a 50% chance of passing the variant to offspring. Genetic counseling is recommended for families to understand their risks and implications for family planning. Associated genes include SRP72.

Question 4

How is autosomal dominant aplasia and myelodysplasia inherited?

Accepted Answer

autosomal dominant aplasia and myelodysplasia follows an autosomal dominant inheritance pattern. This means inheriting just one copy of the altered gene from either parent can cause the condition.

Question 5

How rare is autosomal dominant aplasia and myelodysplasia?

Accepted Answer

autosomal dominant aplasia and myelodysplasia is classified as very rare. The estimated prevalence is approximately <1 in 1,000,000. Because rare disease data can be limited, actual numbers may differ from published estimates.

Question 6

How is autosomal dominant aplasia and myelodysplasia diagnosed?

Accepted Answer

Definitive diagnosis of autosomal dominant aplasia and myelodysplasia is achieved through molecular genetic testing that identifies pathogenic variants in the SRP72 gene. The diagnostic approach also involves a thorough clinical evaluation that considers blood count abnormalities and bone marrow findings. Because symptoms can overlap with other conditions, genetic testing is essential to confirm the diagnosis.

Question 7

Are there treatments for autosomal dominant aplasia and myelodysplasia?

Accepted Answer

Currently, management focuses on supportive care and symptom management, as there are no treatments specifically approved for autosomal dominant aplasia and myelodysplasia. Treatment is tailored to the individual's clinical picture and typically involves a multidisciplinary team to address hematologic and related complications. Regular surveillance is an essential part of long-term care, helping to identify potential complications before they become serious. Genetic counseling is recommended to assist affected families in understanding the condition and planning for the future.

Question 8

Are there clinical trials for autosomal dominant aplasia and myelodysplasia?

Accepted Answer

Yes, there are currently 8 active clinical trials for autosomal dominant aplasia and myelodysplasia registered on ClinicalTrials.gov. Clinical trials test new treatments, procedures, or approaches. Your healthcare provider can help determine if a trial might be appropriate for your situation. Visit the Treatment section of this page for more details.

Question 9

What complications can arise from autosomal dominant aplasia and myelodysplasia?

Accepted Answer

Complications from autosomal dominant aplasia and myelodysplasia can include severe infections due to low blood cell counts, particularly if there is pancytopenia or aplastic anemia. Individuals may also experience fatigue and other symptoms related to their blood count abnormalities. Regular monitoring is important to catch these complications early.

Question 10

How does autosomal dominant aplasia and myelodysplasia affect daily life?

Accepted Answer

Living with autosomal dominant aplasia and myelodysplasia can be challenging due to symptoms like fatigue and increased risk of infections. Individuals may need to adjust their daily activities and seek regular medical care to manage their symptoms effectively. Support from healthcare providers and family can help improve quality of life.

Question 11

What is the prognosis for someone with autosomal dominant aplasia and myelodysplasia?

Accepted Answer

The prognosis for individuals with autosomal dominant aplasia and myelodysplasia varies widely. Some people may experience stabilization of their condition with proper care, while others may have more severe symptoms. Access to specialized care and a multidisciplinary approach can significantly impact outcomes.

Question 12

What specialists should families consult for autosomal dominant aplasia and myelodysplasia?

Accepted Answer

Families affected by autosomal dominant aplasia and myelodysplasia should consider consulting hematologists who specialize in blood disorders. Genetic counselors can also provide valuable information about the condition and family planning. A multidisciplinary team can help address the various aspects of care needed for this condition.

Kisho

autosomal dominant aplasia and myelodysplasia

Overview

Clinical Presentation

Genetic Landscape

Diagnosis

Prognosis

Research Landscape

Recent Publications

Medical References

External Resources

OMIM

Orphanet

GARD

Questions for Your Care Team

Questions for Your Care Team

FAQ

Frequently Asked Questions

Explore clinical features

autosomal dominant aplasia and myelodysplasia

Overview

Clinical Presentation

Genetic Landscape

Diagnosis

Prognosis

Research Landscape

Recent Publications

Medical References

External Resources

OMIM

Orphanet

GARD

Related Diseases

Questions for Your Care Team

Questions for Your Care Team

FAQ

Frequently Asked Questions

What is autosomal dominant aplasia and myelodysplasia?

What are the symptoms of autosomal dominant aplasia and myelodysplasia?

What causes autosomal dominant aplasia and myelodysplasia?

How is autosomal dominant aplasia and myelodysplasia inherited?

How rare is autosomal dominant aplasia and myelodysplasia?

How is autosomal dominant aplasia and myelodysplasia diagnosed?

Are there treatments for autosomal dominant aplasia and myelodysplasia?

Are there clinical trials for autosomal dominant aplasia and myelodysplasia?

What complications can arise from autosomal dominant aplasia and myelodysplasia?

How does autosomal dominant aplasia and myelodysplasia affect daily life?

What is the prognosis for someone with autosomal dominant aplasia and myelodysplasia?

What specialists should families consult for autosomal dominant aplasia and myelodysplasia?

Explore clinical features